|Bid||420.00 x 0|
|Ask||440.00 x 0|
|Day's range||422.36 - 439.80|
|52-week range||110.30 - 460.00|
|Beta (5Y monthly)||1.21|
|PE ratio (TTM)||N/A|
|Earnings date||21 Sep 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||5.03|
Doug Doerfler became the CEO of MaxCyte, Inc. (LON:MXCT) in 1999, and we think it's a good time to look at the...
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Shares in Maxcyte Inc (LON:MXCT) have performed strongly against the market in recent weeks. On a 3-month relative price strength basis, the price is up by 92....